This content is machine translated Psoriatic arthritis (PsoA) Pooled analysis on the efficacy of secukinumab from four phase III studies Improvement in clinical endpoints was seen with secukinumab treatment regardless of latency since initial psoriatic arthritis diagnosis, with patients diagnosed less than one year ago showing a slightly better response…
View Post 4 min This content is machine translated Psoriatic arthritis (PsoA) Cardiovascular risk assessment in PsoA – a current “top priority”. Patients with psoriatic arthritis are at increased risk for metabolic comorbidities and cardiovascular disease. During the World Psoriasis & Psoriatic Arthritis Congress organized by IFPA in Stockholm, various approaches to…
View Post 4 min This content is machine translated Psoriatic arthritis (PsA) From an interdisciplinary perspective, what are the current “Unmet needs”? Psoriatic arthritis (PsA) manifests clinically as a heterogeneous disease with phenotypically highly variable expression. Most of those affected already suffer from skin psoriasis. Predicting which psoriasis patients are at increased risk…
